Francisco Arias
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Longitudinal Cognitive Evolution in Alcohol Use Disorder Patients: Role of Inflammation, Time of Abstinence and Apolipoprotein Profile.
Journal: Addiction biology
Published: March 24, 2026
Silent damage, early signals: A narrative review of the evolving role of cardiac biomarkers in oncology-driven cardiotoxicity.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: September 14, 2025
Changes in neurobiological markers of reactivity to alcohol-related stimuli in alcohol-dependent patients after two years of treatment.
Journal: Frontiers in psychiatry
Published: April 16, 2025
Evaluating Perceptions of the CANreduce 2.0 eHealth Intervention for Cannabis Use: Focus Group Study.
Journal: Journal of medical Internet research
Published: August 05, 2024
How, when, and to what degree do people with alcohol dependence recover their psychological wellbeing and quality of life? The Madrid Recovery Project.
Journal: Frontiers in psychiatry
Published: December 22, 2022
Reelin Plasma Levels Identify Cognitive Decline in Alcohol Use Disorder Patients During Early Abstinence: The Influence of APOE4 Expression.
Journal: The international journal of neuropsychopharmacology
Published: November 14, 2022
Spanish Validation of the Assessment of Recovery Capital Scale in Clinical Population with Alcohol Use Disorder.
Journal: The Spanish journal of psychology
Published: May 03, 2022
A case of Wernicke's encephalopathy that maintains long-term cognitive deterioration but not inflammation in spite of thiamine supplementation.
Journal: Psychiatry and clinical neurosciences
Published: April 29, 2022
Effectiveness of tianeptine in patients with major depressive disorder and substance use disorder.
Journal: Actas espanolas de psiquiatria
Published: July 01, 2021
Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study.
Journal: Drugs - real world outcomes
Published: March 01, 2020
Last Updated: 09/26/2026